183
Views
4
CrossRef citations to date
0
Altmetric
Original Research

The Analysis of Oxidative Stress Markers May Increase the Accuracy of the Differential Diagnosis of Alzheimer’s Disease with and without Depression

, , , , & ORCID Icon
Pages 1105-1117 | Published online: 16 Jun 2021

References

  • Firdaus Z, Singh TD. An insight in pathophysiological mechanism of Alzheimer’s disease and its management using plant natural products. Mini Rev Med Chem. 2020.
  • Uddin MS, Kabir MT, Rahman MS, et al. Revisiting the amyloid cascade hypothesis: from anti-Aβ therapeutics to auspicious new ways for Alzheimer’s disease. InternatIonal Journal of Molecular ScIences. 2020;21(16):1–34. doi:10.3390/ijms21165858
  • Dindelegan CM, Faur D, Purza L, et al. Distress in neurocognitive disorders due to Alzheimer’s disease and stroke. Exp Ther Med. 2020;20(3):2501–2509. doi:10.3892/etm.2020.880632765742
  • Andreu-Reinón ME, Huerta JM, Gavrila D, et al. Incidence of dementia and associated factors in the EPIC-Spain dementia cohort. J Alzheimers Dis. 2020;78(2):543–555. doi:10.3233/JAD-20077433016917
  • Rabin LA, Wang C, Mogle JA, Lipton RB, Derby CA, Katz MJ. An approach to classifying subjective cognitive decline in community-dwelling elders. Alzheimers Dement (Amst). 2020;12(1):e12103.33015309
  • Vlachos GS, Kosmidis MH, Yannakoulia M, et al. Dementia incidence in the elderly population of Greece: results from the HELIAD Study. Alzheimer Dis Assoc Disord. 2020;34(2):156–162. doi:10.1097/WAD.000000000000036131913961
  • Dubal DB. Sex difference in Alzheimer’s disease: an updated, balanced and emerging perspective on differing vulnerabilities. Handb Clin Neurol. 2020;175:261–273.33008530
  • Chan CK, Soldan A, Pettigrew C, Wang J, Albert M, Rosenberg PB; BIOCARD Research Team. Depressive symptoms and CSF Alzheimer’s disease biomarkers in relation to clinical symptom onset of mild cognitive impairment. Alzheimers Dement (Amst). 2020;12(1):e12106.33005725
  • Chan C, Rosenberg PB. Depression synergy with amyloid and increased risk of cognitive decline in preclinical Alzheimer disease. JAMA Netw Open. 2019;2(8):e198970. doi:10.1001/jamanetworkopen.2019.897031397856
  • Al-Kuraishy HM, Abdulhadi M, Hussien N, et al. Involvement of orexinergic system in psychiatric and neurodegenerative disorders: a scoping review. Brain Circ. 2020;6(2):70–80. doi:10.4103/bc.bc_42_1933033776
  • Lévy E, El Banna N, Baïlle D, et al. Causative links between protein aggregation and oxidative stress: a review. Int J Mol Sci. 2019;20(16):3896. doi:10.3390/ijms20163896
  • Pisoschi AM, Pop A, Iordache F, Stanca L, Predoi G, Serban AI. Oxidative stress mitigation by antioxidants - an overview on their chemistry and influences on health status. Eur J Med Chem. 2020;209:112891.33032084
  • Olakkaran S, Kizhakke Purayil A, Antony A, et al. Oxidative stress-mediated genotoxicity of malathion in human lymphocytes. Mutat Res. 2020;849:503138. doi:10.1016/j.mrgentox.2020.50313832087854
  • Koychev I, Hofer M, Friedman N. Correlation of Alzheimer disease neuropathologic staging with amyloid and tau scintigraphic imaging biomarkers. J Nucl Med. 2020;61(10):1413–1418. doi:10.2967/jnumed.119.23045832764121
  • Sun H-L, Chen S-H, Yu Z-Y, et al. Blood cell-produced amyloid-β induces cerebral Alzheimer-type pathologies and behavioral deficits. Mol Psychiatry. 2020. doi:10.1038/s41380-020-0842-1
  • Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, et al. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol. 2020;16(1):30–42. doi:10.1038/s41582-019-0281-231827267
  • Gourmaud S, Shou H, Irwin DJ, et al. Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy. Brain. 2020;143(1):191–209. doi:10.1093/brain/awz38131834353
  • Mavroudis I, Petridis F, Chatzikonstantinou S, et al. Alpha-synuclein levels in the differential diagnosis of Lewy bodies dementia and other neurodegenerative disorders: a meta-analysis. Alzheimer Dis Assoc Disord. 2020;34(3):220–224. doi:10.1097/WAD.000000000000038132341240
  • Banning LCP, Ramakers IHGB, Deckers K, et al. Affective symptoms and AT(N) biomarkers in mild cognitive impairment and Alzheimer’s disease: a systematic literature review. Neurosci Biobehav Rev. 2019;107:346–359. doi:10.1016/j.neubiorev.2019.09.01431525387
  • Kaufmann FN, Costa AP, Ghisleni G, et al. NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings. Brain Behav Immun. 2017;64:367–383.28263786
  • Kohman RA, Rhodes JS. The contribution of adult hippocampal neurogenesis to the progression of psychiatric disorders. Mod Trends Pharmacopsychiatry. 2017;31:124–151.28738394
  • Singhal G, Jaehne EJ, Corrigan F, et al. Inflammasomes in neuroinflammation and changes in brain function: a focused review. Front Neurosci. 2014;8:315. doi:10.3389/fnins.2014.0031525339862
  • Singhal G, Baune BT. Microglia: an interface between the loss of neuroplasticity and depression. Front Cell Neurosci. 2017;11:270. doi:10.3389/fncel.2017.0027028943841
  • Fiske A, Loebach Wetherell J, Gatz M. Depression in older adults. Annu Rev Clin Psychol. 2009;5(1):363–389. doi:10.1146/annurev.clinpsy.032408.15362119327033
  • Mohn C, Rund BR. Neurocognitive profile in major depressive disorders: relationship to symptom level and subjective memory complaints. BMC Psychiatry. 2016;16(1):108. doi:10.1186/s12888-016-0815-827095362
  • Ramirez-Gomez L, Zheng L, Reed B, et al. Neuropsychological profiles differentiate Alzheimer disease from subcortical ischemic vascular dementia in an autopsy-defined cohort. Dement Geriatr Cogn Disord. 2017;44(1–2):1–11. doi:10.1159/00047734428595184
  • Moradi E, Hallikainen I, Hänninen T, et al.; Alzheimer’s Disease Neuroimaging Initiative. Rey’s Auditory Verbal Learning Test scores can be predicted from whole brain MRI in Alzheimer’s disease. Neuroimage Clin. 2017;13:415–427. doi:10.1016/j.nicl.2016.12.01128116234
  • Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase.. The Journal of Biological Chemistry. 1972;247(10):3170–3175.4623845
  • Bellavite P, Dri P, Della Bianca V, et al. The measurement of superoxide anion production by granulocytes In whole blood. A clinical test for the evaluation of phagocyte function and serum opsonic capacity. Eur J Clin Invest. 1983;13(4):363–368. doi:10.1111/j.1365-2362.1983.tb00114.x6311564
  • Ighodaro O, Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid. Alexandria J Med. 2017.
  • Borgstahl GEO, Oberley-Deegan RE. Superoxide dismutases (SODs) and SOD mimetics. Antioxidants (Basel). 2018;7(11).
  • Gsell W, Conrad R, Hickethier M, et al. Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J Neurochem. 1995;64(3):1216–1223. doi:10.1046/j.1471-4159.1995.64031216.x7861154
  • Thome J, Gsell W, Rösier M, et al. Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer’s disease. Life Sci. 1997;60(1):13–19. doi:10.1016/S0024-3205(96)00583-88995527
  • Chang YT, Chang W-N, Tsai N-W, et al. The roles of biomarkers of oxidative stress and antioxidant in Alzheimer’s disease: a systematic review. Biomed Res Int. 2014;2014:182303. doi:10.1155/2014/18230324949424
  • Jutten RJ, Sikkes SA, Amariglio RE, et al. Identifying sensitive measures of cognitive decline at different clinical stages of alzheimer’s disease. J Int Neuropsychol Soc. 2020;1–13.
  • Hammers DB, Kucera A, Spencer RJ, et al. Examining the relationship between a verbal incidental learning measure from the WAIS-IV and neuroimaging biomarkers for Alzheimer’s pathology. Dev Neuropsychol. 2020;45(3):95–109. doi:10.1080/87565641.2020.176260232374196
  • Terrera GM, Harrison JE, Ritchie CW, et al. Cognitive functions as predictors of Alzheimer’s disease biomarker status in the European prevention of Alzheimer’s dementia cohort. J Alzheimers Dis. 2020;74(4):1203–1210. doi:10.3233/JAD-19110832144988
  • Snytte J, Elshiekh A, Subramaniapillai S, et al. The ratio of posterior-anterior medial temporal lobe volumes predicts source memory performance in healthy young adults. Hippocampus. 2020;30(11):1209–1227. doi:10.1002/hipo.2325132830426
  • Schwab S, Afyouni S, Chen Y, et al. Functional connectivity alterations of the temporal lobe and hippocampus in semantic dementia and Alzheimer’s disease. J Alzheimers Dis. 2020;76(4):1461–1475. doi:10.3233/JAD-19111332651312
  • Tang L, Pruitt PJ, Yu Q, et al. Differential functional connectivity in anterior and posterior hippocampus supporting the development of memory formation. Front Hum Neurosci. 2020;14:204. doi:10.3389/fnhum.2020.0020432581749
  • Hao L, Xing Y, Li X, et al. Risk factors and neuropsychological assessments of subjective cognitive decline. Front Neurosci. 2019;13:846. doi:10.3389/fnins.2019.0084631474820
  • Xu Y, Chen K, Zhao Q, et al. Short-term delayed recall of auditory verbal learning test provides equivalent value to long-term delayed recall in predicting MCI clinical outcomes: a Longitudinal Follow-Up Study. Appl Neuropsychol Adult. 2020;27(1):73–81. doi:10.1080/23279095.2018.148106730470140
  • Hong X, Zhang Z-X, Wu L-Y, et al. Validity of auditory verbal learning test in diagnosis of Alzheimer’s disease. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012;34(3):262–266. doi:10.3881/j.issn.1000-503X.2012.03.01422776661
  • Zhao Q, Guo Q, Liang X, et al. Auditory verbal learning test is superior to rey-osterrieth complex figure memory for predicting mild cognitive impairment to Alzheimer’s disease. Curr Alzheimer Res. 2015;12(6):520–526. doi:10.2174/156720501266615053020272926027810
  • Rizk-Jackson A, Insel P, Petersen R, et al. Early indications of future cognitive decline: stable versus declining controls. PLoS One. 2013;8(9):e74062. doi:10.1371/journal.pone.007406224040166
  • Loring DW, Goldstein FC, Chen C, et al. False-positive error rates for reliable digit span and auditory verbal learning test performance validity measures in amnestic mild cognitive impairment and early Alzheimer disease. Arch Clin Neuropsychol. 2016;31(4):313–331. doi:10.1093/arclin/acw01427084732
  • Shao A, Lin D, Wang L, et al. Oxidative stress at the crossroads of aging, stroke and depression. Aging Dis. 2020;11(6):1537–1566. doi:10.14336/AD.2020.022533269106
  • Manosso LM, Camargo A, Dafre AL, et al. Vitamin E for the management of major depressive disorder: possible role of the anti-inflammatory and antioxidant systems. Nutr Neurosci. 2020;1–15. doi:10.1080/1028415X.2020.1853417
  • Farhadnejad H, Neshatbini Tehrani A, Salehpour A, et al. Antioxidant vitamin intakes and risk of depression, anxiety and stress among female adolescents. Clin Nutr ESPEN. 2020;40:257–262. doi:10.1016/j.clnesp.2020.09.01033183546
  • Tanvir S, Asif N, Qayyum R, et al. Trace metal profiling in patients with depression in Pakistani population. J Pak Med Assoc. 2020;70(11):1883–1886. doi:10.5455/JPMA.615433341824
  • Behr GA, Moreira JC, Frey BN. Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder. Oxid Med Cell Longiv. 2012;609421.
  • Kotan VO, Sarandol E, Kirhan EIW, Ozkaya G, Kirli S. Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-Week Follow-Up Study. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(5):1284–1290. doi:10.1016/j.pnpbp.2011.03.02121515329
  • Amunts J, Camilleri JA, Eickhoff SB, et al. Executive functions predict verbal fluency scores in healthy participants. Sci Rep. 2020;10(1):11141. doi:10.1038/s41598-020-65525-932636406
  • Guzzetti S, Mancini F, Caporali A, et al. The association of cognitive reserve with motor and cognitive functions for different stages of Parkinson’s disease. Exp Gerontol. 2019;115:79–87. doi:10.1016/j.exger.2018.11.02030502539
  • Mougias A, Christidi F, Synetou M, et al. Differential effect of demographics, processing speed, and depression on cognitive function in 755 non-demented community-dwelling elderly individuals. Cogn Behav Neurol. 2019;32(4):236–246. doi:10.1097/WNN.000000000000021131800484
  • Olabarrieta-Landa L, Benito-Sánchez I, Alegret M, et al. Letter verbal fluency in Spanish-, Basque-, and Catalan-speaking individuals: does the selection of the letters influence the outcome? J Speech Lang Hear Res. 2019;62(7):2400–2410. doi:10.1044/2019_JSLHR-L-18-036531216206
  • Sejunaite K, Lanza C, Riepe MW. Everyday memory in healthy aging: porous but not distorted. Front Aging Neurosci. 2019;11:153. doi:10.3389/fnagi.2019.0015331293413
  • Sejunaite K, Lanza C, Riepe MW. Everyday false memories in older persons with depressive disorder. Psychiatry Res. 2018;261:456–463. doi:10.1016/j.psychres.2018.01.03029407717
  • Sejunaite K, Lanza C, Riepe MW. Everyday memory in patients with Alzheimer’s disease: fragmentary and distorted. J Alzheimers Dis. 2017;60(4):1489–1498. doi:10.3233/JAD-17049329060940
  • Shao Z, Janse E, Visser K, et al. What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults. Front Psychol. 2014;5:772. doi:10.3389/fpsyg.2014.0077225101034
  • Zhang FF, Peng W, Sweeney JA, et al. Brain structure alterations in depression: psychoradiological evidence. CNS Neurosci Ther. 2018;24(11):994–1003. doi:10.1111/cns.1283529508560